COVID-19 Outbreak-Global Vertigo Industry Market Report-Development Trends, Threats, Opportunities and Competitive Landscape in 2020
By Maia Research | Pharmaceuticals and Healthcare | Sep 2020 | Page 117
Peripheral vertigo can be further segmented into five major categories: Benign paroxysmal positional vertigo (BPPV), Acute Unilateral Vestibulopathy, Menieres disease and Vestibular Schwannoma. Amongst all the stated indication, Menieres disease....
COVID-19 Outbreak-Global Inosine Pranobex Industry Market Report-Development Trends, Threats, Opportunities and Competitive Landscape in 2020
By Maia Research | Pharmaceuticals and Healthcare | Sep 2020 | Page 124
The Inosine Pranobex market revenue was xx.xx Million USD in 2019, and will reach xx.xx Million USD in 2025, with a CAGR of x.x% during 2020-2025. Under COVID-19 outbreak globally, this....
COVID-19 Outbreak-Global Hyaluronic Acid Filler and Botulinum A (Botox) Industry Market Report-Development Trends, Threats, Opportunities and Competitive Landscape in 2020
By Maia Research | Pharmaceuticals and Healthcare | Sep 2020 | Page 119
The Hyaluronic Acid Filler and Botulinum A (Botox) market revenue was xx.xx Million USD in 2019, and will reach xx.xx Million USD in 2025, with a CAGR of x.x% during....
COVID-19 Outbreak-Global Sacral Nerve Stimulation Devices Industry Market Report-Development Trends, Threats, Opportunities and Competitive Landscape in 2020
By Maia Research | Pharmaceuticals and Healthcare | Sep 2020 | Page 103
Sacral nerve stimulation (SNS) is a medical electrical stimulation therapy that is used to treat long-term bowel control and bladder control symptoms through the modulation of nerves controlling the lower....
COVID-19 Outbreak-Global Amlodipine and Olmesartan Industry Market Report-Development Trends, Threats, Opportunities and Competitive Landscape in 2020
By Maia Research | Pharmaceuticals and Healthcare | Sep 2020 | Page 106
Amlodipine and olmesartan is a combination of medicines that may be used alone or with other medicines to treat high blood pressure (hypertension). The Amlodipine and Olmesartan market revenue was xx.xx....